29/01/2026
We are very excited to announce a Perron Institute-led project has received a substantial funding pledge from the Stan Perron Charitable Foundation. The funding opens the way for researchers and co-contributors to design and pilot a model to improve treatment for depression and anxiety for introducing pharmacogenetics-guided prescribing of anti-depressants.
“Mental health conditions such as depression are the leading cause of disease burden among young people in WA but more than half do not respond well to initial treatment,” said Consultant Psychiatrist Professor Sean Hood The University of Western Australia, Chief Investigator for this project.
Chief Investigator Prof Jennifer Rodger (Perron Institute|UWA) said the study was a response to findings from studies including the GENE-YD project which included concerns raised by WA youth and clinicians who have called for mental health care that is more effective, person-centred, and responsive to patient needs. The PGx-ADAPT project targeting 16–24 year olds, aims to address system-level barriers to implementing pharmacogenetics by generating feasibility data across both metropolitan and rural WA settings.
This collaborative project involves a wide range of medical, education, policy and economics researchers, clinicians and community representatives.
Partner organisations include: Perron Institute, UWA, Gene S, Sequence2Script Inc. PARTNER Network, Lyfe Languages, Australian Alliance for Indigenous Genomics (ALIGN), Royal Australian College of General Practitioners (RACGP), Bankwest Curtin Economics Centre (BCEC), and WA Health Department.